Protara Therapeutics (TARA) SEC Filings & 10K Form

$3.00
+0.18 (+6.38%)
(As of 03:28 PM ET)

Recent Protara Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2024
9:43 AM
CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G
04/05/2024
7:14 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:17 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:11 PM
ORBIMED ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G/A
01/23/2024
3:05 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Bandari Jathin (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:05 PM
Bandari Jathin (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:30 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:35 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
11:15 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form EFFECT
11/03/2023
7:31 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/03/2023
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
7:20 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
7:20 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
7:12 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
6:26 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2023
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TARA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners